Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 06, 2019 | February 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 06, 2019 · Filed February 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 3,400 |
Reported balance
After 2019-06-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-06-06 · Sale · Disposed 200 · Balance 3,400 F1: On June 6, 2019, Mr. Pankau sold an aggregate of 200 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $200.36 to $200.46. The Company maintains a record of the transactions and copies will be provided upon request. F2: As of the date of this filing, Mr. Pankau owns 3,706 shares of CME Group Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 6, 2019, Mr. Pankau sold an aggregate of 200 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $200.36 to $200.46. The Company maintains a record of the transactions and copies will be provided upon request.
F2: As of the date of this filing, Mr. Pankau owns 3,706 shares of CME Group Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2019 Filed Nov 15, 2019 21:23 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $199.02 | $59,706.00 |
DisclosureSEC source: 0001156375-19-000115 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,906 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:39 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 606 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000078 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,206 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 06, 2019 Filed Feb 28, 2020 20:47 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 200 | $200.36 | $40,072.00 |
DisclosureSEC source: 0001156375-20-000016 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 F1 · price: On June 6, 2019, Mr. Pankau sold an aggregate of 200 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $200.36 to $200.46. The Company maintains a record of the transactions and copies will be provided upon request. F2 · balance_after: As of the date of this filing, Mr. Pankau owns 3,706 shares of CME Group Class A common stock. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 16:15 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 200 | $182.90 | $36,580.00 |
DisclosureSEC source: 0001156375-19-000013 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:42 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 187 | $190.00 | $35,530.00 |
DisclosureSEC source: 0001156375-18-000137 · primary_doc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:13 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000114 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,987 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 260 | $163.17 | $42,424.20 |
DisclosureSEC source: 0001156375-18-000085 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:41 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000068 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 15:56 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 250 | $171.51 | $42,877.50 |
DisclosureSEC source: 0001156375-18-000055 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,559 Read SEC document |
| February 14, 2018 Filed Feb 15, 2018 20:28 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 200 | $159.91 | $31,982.00 |
DisclosureSEC source: 0001156375-18-000021 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,809 F1 · price: On February 14, 2018, Mr. Pankau sold an aggregate of 200 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were $159.88 to $159.93. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| August 03, 2017 Filed Aug 3, 2017 20:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $124.78 | $37,434.00 |
DisclosureSEC source: 0001156375-17-000082 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:59 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000065 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,309 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 500 | $122.11 | $61,055.00 |
DisclosureSEC source: 0001156375-17-000019 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 23:23 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 382 | $123.53 | $47,188.46 |
DisclosureSEC source: 0001156375-16-000264 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.